BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Topp L, Day CA, Wand H, Deacon RM, van Beek I, Haber PS, Shanahan M, Rodgers C, Maher L; Hepatitis Acceptability and Vaccine Incentives Trial (HAVIT) Study Group. A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Prev Med. 2013;57:297-303. [PMID: 23639625 DOI: 10.1016/j.ypmed.2013.04.013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Calin R, Massari V, Pialoux G, Reydellet N, Plenel E, Chauvin C, Jauffret-Roustide M, Day N, Kreplak G, Maresca AF, Derche N, Louis S, Pol S, Doré V, Rouzioux C, Chauvin P. Acceptability of on-site rapid HIV/HBV/HCV testing and HBV vaccination among three at-risk populations in distinct community-healthcare outreach centres: the ANRS-SHS 154 CUBE study. BMC Infect Dis 2020;20:851. [PMID: 33198672 DOI: 10.1186/s12879-020-05601-7] [Reference Citation Analysis]
2 Crewe Dixon T, Stein E, Ngak S, Srean C, Maly P, Sokunny M, Carrico A, Page K, Maher L. Qualitative research and implementation science: Informing the acceptability and implementation of a trial of a conditional cash transfer intervention designed to reduce drug use and HIV risk. Method Innov 2016;9. [PMID: 30956811 DOI: 10.1177/2059799115622751] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
3 Rafia R, Dodd PJ, Brennan A, Meier PS, Hope VD, Ncube F, Byford S, Tie H, Metrebian N, Hellier J, Weaver T, Strang J. An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence. Addiction 2016;111:1616-27. [PMID: 26990598 DOI: 10.1111/add.13385] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Gopalan A, Shaw PA, Lim R, Paramanund J, Patel D, Zhu J, Volpp KG, Buttenheim AM. Use of financial incentives and text message feedback to increase healthy food purchases in a grocery store cash back program: a randomized controlled trial. BMC Public Health 2019;19:674. [PMID: 31151390 DOI: 10.1186/s12889-019-6936-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Abadie R, Brown B, Fisher CB. "Money Helps": People who inject drugs and their perceptions of financial compensation and its ethical implications. Ethics Behav 2019;29:607-20. [PMID: 31579222 DOI: 10.1080/10508422.2018.1535976] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 [DOI: 10.1101/2021.05.16.21257290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Roncero C, Ryan P, Littlewood R, Macías J, Ruiz J, Seijo P, Palma-Álvarez RF, Vega P. Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder. Hepat Med 2019;11:1-11. [PMID: 30613166 DOI: 10.2147/HMER.S187133] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Dolan P, Rudisill C. The effect of financial incentives on chlamydia testing rates: evidence from a randomized experiment. Soc Sci Med 2014;105:140-8. [PMID: 24373390 DOI: 10.1016/j.socscimed.2013.11.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
9 Tressler S, Bhandari R. Interventions to Increase Completion of Hepatitis B Vaccination in People who Inject Drugs: A Systematic Review and Meta-analysis. Open Forum Infect Dis 2019;6:ofz521. [PMID: 31890724 DOI: 10.1093/ofid/ofz521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Walsh N, Verster A, Rodolph M, Akl EA. WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs. Int J Drug Policy 2014;25:363-71. [PMID: 24561223 DOI: 10.1016/j.drugpo.2014.01.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
11 Epstein D, Enticott J, Larson H, Barton C. Pragmatic cluster randomised control trial using Vaxcards as an age-appropriate tool to incentivise and educate school students about vaccination. BMJ Open 2021;11:e049562. [PMID: 34475171 DOI: 10.1136/bmjopen-2021-049562] [Reference Citation Analysis]
12 Koyama Y, Fujiwara T, Isumi A, Doi S. Is Japan's child allowance effective for the well-being of children? A statistical evaluation using data from K-CHILD study. BMC Public Health 2020;20:1503. [PMID: 33023534 DOI: 10.1186/s12889-020-09367-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Weaver T, Metrebian N, Hellier J, Pilling S, Charles V, Little N, Poovendran D, Mitcheson L, Ryan F, Bowden-Jones O. Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial. Lancet. 2014;384:153-163. [PMID: 24725468 DOI: 10.1016/s0140-6736(14)60196-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
14 Neale J, Tompkins CN, Strang J. Qualitative evaluation of a novel contingency management-related intervention for patients receiving supervised injectable opioid treatment. Addiction 2016;111:665-74. [PMID: 26498274 DOI: 10.1111/add.13212] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
15 Stone J, Martin NK, Hickman M, Hellard M, Scott N, McBryde E, Drummer H, Vickerman P. The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals? PLoS One 2016;11:e0156213. [PMID: 27224423 DOI: 10.1371/journal.pone.0156213] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
16 Haber PS, Day CA, Topp L, Shanahan M, Wand H, van Beek I, Maher L. Hepatitis B vaccination for people who inject drugs. Lancet 2015;385:115. [PMID: 25706466 DOI: 10.1016/S0140-6736(15)60019-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Feng Y, Shi J, Gao L, Yao T, Feng D, Luo D, Li Z, Zhang Y, Wang F, Cui F, Li L, Liang X, Wang S. Immunogenicity and safety of high-dose hepatitis B vaccine among drug users: A randomized, open-labeled, blank-controlled trial. Hum Vaccin Immunother 2017;13:1-7. [PMID: 28301282 DOI: 10.1080/21645515.2017.1283082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
18 Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing Vaccination: Putting Psychological Science Into Action. Psychol Sci Public Interest 2017;18:149-207. [DOI: 10.1177/1529100618760521] [Cited by in Crossref: 211] [Cited by in F6Publishing: 182] [Article Influence: 52.8] [Reference Citation Analysis]
19 Ghomraoui FA, Alfaqeeh FA, Algadheeb AS, Al-Alsheikh AS, Al-Hamoudi WK, Alswat KA. Medical students' awareness of and compliance with the hepatitis B vaccine in a tertiary care academic hospital: An epidemiological study. J Infect Public Health 2016;9:60-5. [PMID: 26185014 DOI: 10.1016/j.jiph.2015.06.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
20 Bowman S, Grau LE, Singer M, Scott G, Heimer R. Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities. BMC Public Health 2014;14:820. [PMID: 25107530 DOI: 10.1186/1471-2458-14-820] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
21 Treloar C, Hopwood M, Cama E, Saunders V, Jackson LC, Walker M, Ooi C, Ubrihien A, Ward J. Evaluation of the Deadly Liver Mob program: insights for roll-out and scale-up of a pilot program to engage Aboriginal Australians in hepatitis C and sexual health education, screening, and care. Harm Reduct J 2018;15:5. [PMID: 29391019 DOI: 10.1186/s12954-018-0209-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
22 Wadhera P, Evans JL, Stein E, Gandhi M, Couture MC, Sansothy N, Sichan K, Maher L, Kaldor J, Page K, Kien; YWHS Collaborative. Human papillomavirus knowledge, vaccine acceptance, and vaccine series completion among female entertainment and sex workers in Phnom Penh, Cambodia: the Young Women's Health Study. Int J STD AIDS 2015;26:893-902. [PMID: 25505042 DOI: 10.1177/0956462414563626] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
23 Palmer AY, Chan K, Gold J, Layton C, Elsum I, Hellard M, Stoove M, Doyle JS, Pedrana A, Scott N; on the EC Partnership. A modelling analysis of financial incentives for hepatitis C testing and treatment uptake delivered through a community-based testing campaign. J Viral Hepat 2021;28:1624-34. [PMID: 34415639 DOI: 10.1111/jvh.13596] [Reference Citation Analysis]
24 Stitzer M, Calsyn D, Matheson T, Sorensen J, Gooden L, Metsch L. Development of a Multi-Target Contingency Management Intervention for HIV Positive Substance Users. J Subst Abuse Treat 2017;72:66-71. [PMID: 27624618 DOI: 10.1016/j.jsat.2016.08.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
25 Olsen A, Wallace J, Maher L. Responding to Australia's National Hepatitis B Strategy 2010-13: gaps in knowledge and practice in relation to Indigenous Australians. Aust J Prim Health 2014;20:134-42. [PMID: 24216010 DOI: 10.1071/PY12162] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
26 Iversen J, Peacock A, Price O, Byrne J, Dunlop A, Maher L. COVID-19 vaccination among people who inject drugs: Leaving no one behind. Drug Alcohol Rev 2021;40:517-20. [PMID: 33650174 DOI: 10.1111/dar.13273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Price O, Dietze P, Sullivan SG, Salom C, Peacock A. Uptake, barriers and correlates of influenza vaccination among people who inject drugs in Australia. Drug Alcohol Depend 2021;226:108882. [PMID: 34216866 DOI: 10.1016/j.drugalcdep.2021.108882] [Reference Citation Analysis]
28 Boyd A, Bottero J, Carrat F, Gozlan J, Rougier H, Girard PM, Lacombe K. Testing for hepatitis B virus alone does not increase vaccine coverage in non-immunized persons. World J Gastroenterol 2017; 23(38): 7037-7046 [PMID: 29097876 DOI: 10.3748/wjg.v23.i38.7037] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
29 Higgs P, Doyle J, Luppi J, Dietze P, Hellard M. Field engagement further facilitates hepatitis B vaccination completion: Letter in response to: Day et al. (in press). J Clin Virol 2016;82:64-5. [PMID: 27448171 DOI: 10.1016/j.jcv.2016.07.006] [Reference Citation Analysis]
30 Day CA, Shanahan M, Wand H, Topp L, Haber PS, Rodgers C, Deacon R, Walsh N, Kaldor J, van Beek I, Maher L; Hepatitis Acceptability Group Vaccine Incentives Trial Study Group. Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial. J Clin Virol 2016;74:66-72. [PMID: 26679830 DOI: 10.1016/j.jcv.2015.11.031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
31 Herrmann ES, Matusiewicz AK, Stitzer ML, Higgins ST, Sigmon SC, Heil SH. Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review. J Subst Abuse Treat 2017;72:117-25. [PMID: 27394070 DOI: 10.1016/j.jsat.2016.06.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
32 Mirzazadeh A, Hosseini-Hooshyar S, Shahesmaeili A, Bahramnejad A, Barshan A, Mousavian G, Najafi E, Sharifi H, Haghdoost AA, Briceno A, McFarland W, Page K. Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran. Subst Abuse Treat Prev Policy 2020;15:56. [PMID: 32758246 DOI: 10.1186/s13011-020-00298-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Johnson KD, Lu X, Zhang D. Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study. BMC Public Health 2019;19:404. [PMID: 30987613 DOI: 10.1186/s12889-019-6693-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
34 Metrebian N, Weaver T, Pilling S, Goldsmith K, Carr E, Shearer J, Woolston-Thomas K, Tas B, Getty CA, Cooper C, van der Waal R, Kelleher M, Finch E, Bijral P, Taylor D, Scott J, Strang J. Telephone delivered incentives for encouraging adherence to supervised methadone consumption (TIES): Study protocol for a feasibility study for an RCT of clinical and cost effectiveness. Contemp Clin Trials Commun 2020;17:100506. [PMID: 31909291 DOI: 10.1016/j.conctc.2019.100506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 de Dassel JL, Ralph AP, Cass A. A systematic review of adherence in Indigenous Australians: an opportunity to improve chronic condition management. BMC Health Serv Res 2017;17:845. [PMID: 29282117 DOI: 10.1186/s12913-017-2794-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
36 Fleming T, Valleriani J, Ng C, Maher L, Small W, McNeil R. Acceptability of a hypothetical preventative HIV vaccine among people who use drugs in Vancouver, Canada. BMC Public Health 2020;20:1081. [PMID: 32646390 DOI: 10.1186/s12889-020-09202-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Brouard C, Pillonel J, Sogni P, Chollet A, Lazarus JV, Pascal X, Barin F, Jauffret-Roustide M; ANRS Coquelicot Survey Group. Hepatitis B virus in drug users in France: prevalence and vaccination history, ANRS-Coquelicot Survey 2011-2013. Epidemiol Infect 2017;:1-11. [PMID: 28100289 DOI: 10.1017/S0950268816003137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]